— Know what they know.
Not Investment Advice

LQDA NASDAQ

Liquidia Corporation
1W: +4.5% 1M: +67.2% 3M: +84.5% YTD: +97.4% 1Y: +264.1% 3Y: +725.2% 5Y: +2178.3%
$60.98
-0.99 (-1.60%)
 
Weekly Expected Move ±14.0%
$41 $49 $57 $65 $73
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 74 · $5.4B mcap · 62M float · 2.37% daily turnover · Short 43% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$158M +1031.2% ▲
5Y CAGR: +192.5%
Gross Profit
$154M +1796.0% ▲
5Y CAGR: +214.3%
Operating Income
-$51M +57.6% ▲
Net Income
-$69M +47.1% ▲
EPS (Diluted)
$-0.80 +51.8% ▲
EBITDA
-$50M +56.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$13M$16M$17M$14M$158M
YoY Growth+1637.8%+24.0%+9.7%-20.0%+1031.2%
Cost of Revenue$3M$3M$3M$6M$4M
Gross Profit$10M$13M$15M$8M$154M
Gross Margin76.5%82.1%83.5%58.0%97.2%
R&D Expenses$21M$19M$43M$48M$39M
SG&A Expenses$23M$32M$45M$82M$157M
Operating Expenses$44M$52M$88M$129M$205M
Operating Income-$34M-$39M-$73M-$121M-$51M
Operating Margin-263.0%-243.3%-419.6%-866.6%-32.5%
Interest Expense$762K$2M$6M$12M$24M
Income Before Tax-$35M-$41M-$79M-$130M-$69M
Tax Expense$0$0$0$0$0
Net Income-$35M-$41M-$79M-$130M-$69M
Net Margin-269.0%-257.4%-448.9%-931.7%-43.5%
EPS (Diluted)$-0.70$-0.67$-1.21$-1.66$-0.80
EBITDA-$28M-$35M-$70M-$116M-$50M
Shares Outstanding50M61M65M79M86M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms